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CASE PRESENTATION
A 4-year-old boy weighing 15 kg presented with a 3-day
history of vomiting, decreased appetite, and 2 days of non-
bloody diarrhea. He was “warm to the touch” according
to the parents, but no direct measurement of temperature
was taken. An older sibling had had a similar illness 5 days
prior to the onset of vomiting by the patient.
For the previous 2 days, the patient had ingested only
water, apple juice, and non-cola soft drinks. The parents
believed that his urine output had dropped but only in
the previous 12 hours. The patient’s past medical history
and review of systems were unremarkable. He took no
medications on a chronic basis, although acetaminophen
in appropriate doses was used by the family “when the
child felt warm” (2–3 times/day).
On physical examination, he was mildly irritable and
appeared somewhat uncomfortable while sitting quietly
on his parent’s lap. The oral temperature was 38.2◦C;
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blood pressure, 90/64 mm Hg while seated; heart rate,
120 beats/min; and respiratory rate, 24 breaths/min. His
skin was warm without rashes or edema. The head, ears,
eyes, nose, and throat revealed a somewhat dry oral mu-
cosa but no other abnormal findings. His neck was sup-
ple without significant lymphadenopathy or thyromegaly.
Chest examination revealed normal lung sounds with no
murmur. The abdomen was slightly distended and tym-
panic with active bowel sounds and no organomegaly or
masses. There was no costovertebral angle tenderness.
The patient had very slight peri-anal redness; the rest of
the genitourinary exam was normal. His joints were not
red, full, or tender, and he had full range of motion of his
arms and legs.
Urinalysis revealed a specific gravity of 1.020; 1+ pro-
tein, and negative for blood, bilirubin, glucose, leukocyte
esterase, and nitrate; trace ketones; 1 to 2 white blood
cells/high-power field, and 1 granular cast. Blood stud-
ies disclosed: sodium, 128 mEq/L; potassium, 3.6 mEq/L;
chloride, 98 mEq/L; bicarbonate, 18 mmol/L; serum crea-
tinine, 0.7 mg/dL; and blood urea nitrogen, 26 mg/dL.
The parents were concerned because the child contin-
ued to vomit.
DISCUSSION
DR. AARON L. FRIEDMAN (Sylvia Kay Hassenfeld Pro-
fessor and Chairman, Department of Pediatrics, Brown
Medical School and Hasbro Children’s Hospital, Provi-
dence, Rhode Island): This clinical scenario, common in
pediatrics, reflects a typical problem in fluid and elec-
trolyte management. Why should this become the subject
of a Nephrology Forum? Isn’t this issue well understood
not only by nephrologists but by a large percentage of
other clinicians? Is there anything new in the arena of
the management of fluid and electrolyte disorders? The
following discussion not only addresses these questions
but also looks at the physiology that underlies our un-
derstanding of fluid and electrolyte disorders, especially
those associated with abnormalities of body fluid com-
partments as manifested by physical findings and abnor-
mal extracellular electrolyte concentrations.
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In the preface to his remarkable book, The Kidney:
Structure and Function in Health and Disease [1], Homer
Smith quotes Claude/Bernard (1878): “Higher animals
have really two environments: a milieu exterieur in which
the organism is situated, and a milieu interieur in which
the tissue elements live. The living organism does not
really exist in the milieu exterieur (the atmosphere if it
breathes, salt or fresh water if that is its element) but
in the liquid which surrounds and bathes all the tissue
elements. . .the milieu interieur surrounding the organs,
the tissues and their elements never varies; atmospheric
changes cannot penetrate beyond it and it is therefore
true to say that the physical conditions of the environ-
ment are unchanging in the higher animal. . . . Here we
have an organism which has enclosed itself in a kind of
hothouse. . .. All the vital mechanisms, however varied they
may be, have only one object, that of preserving constant
the conditions of life in the internal environment.”
Smith’s footnote on this paragraph ends with, “His con-
cept of the constancy of the internal environment was,
however, perhaps his greatest contribution.” Haldane has
said, “No more pregnant sentence was ever formed by
a physiologist.” Fluid and electrolyte management is a
quintessential example of “preserving constant the con-
ditions of life,” in other words, homeostasis.
Our understanding of body fluid physiology clearly
has advanced since Bernard’s description, although his
picture of the fluid that surrounds cells—“a kind of
hothouse”–is a wonderfully vivid picture. What is our
present understanding of body fluid compartments, how
has it evolved, and how does this understanding inform
fluid and electrolyte management?
Historical review
In 1878, Bernard had little data upon which to make his
statement about the internal milieu of higher organisms.
In the early 20th century, physiologists began to construct
a more complete picture of body fluid compartments.
Gamble et al embarked on studies in 1914 that culmi-
nated in a seminal manuscript published in 1928 [2]. They
introduced the concept of extracellular fluid (ECF), and
carefully described the electrolyte composition of extra-
cellular space. They derived this basic description while
studying the influence of fasting (used to treat seizures)
on acid-base status in children. That study plus later stud-
ies by Gamble and Ross [3] described the renal response
to ECF depletion. The kidney’s ability to respond seemed
“designed” to minimize ECF loss because severe ECF
reduction is life threatening. These studies formed the
foundation of body fluid physiology and our therapeutic
approach to maintaining body fluid homeostasis.
In the 1940s, Gamble described extracellular fluid as
an “enclosed sea” [4]. The total volume of ECF in adults
was measured using the volume of distribution of inulin
after a 2-hour intravenous infusion at approximately 150
to 160 mL/kg [including plasma volume (PV) and inter-
stitial fluid (ISF)] [5]. Since then, our view of ECF has
undergone further refinement. First, more recent mea-
surements of ECF using 6-hour chloride equilibration
techniques found that earlier measurements did not
fully account for ISF in skin and connective tissue. This
changed the total recognized volume of ECF to approxi-
mately 270 mL/kg in adults [6] and 300 mL/kg in children
[7]. Second, ECF obviously is not really a “sea” but, to a
large degree, a gel. The ISF of muscle and other organs is
a complex collagen matrix that provides structure to the
ISF, limiting the effect of gravity. It imposes structural
integrity on intercellular and intercapillary space, allow-
ing for nutrient delivery to cells and removal of the end
products of metabolism [8]. In skin and connective tis-
sue, a somewhat different but equally important collagen-
proteoglycan gel comprises the ISF. This gel is especially
important in structure and function of connective tissue
and bone [9]. This gel backbone slows the exchange of
fluid between the plasma and interstitial space and limits
the “collapse” of the interstitial space when dehydration
occurs.
The complex interaction of the fluid exchange between
plasma and the interstitium involves hydrostatic and in-
terstitial pressures (Starling forces); filtration coefficients,
size and charge of proteins and other solutes; and grav-
ity and lymphatic flow, to name a few. Discussion of this
complex association is beyond the scope of this report but
is reviewed elsewhere [7, 10–12]. Essential to a discussion
of fluid therapy is an understanding that ISF serves as a
reservoir and that in episodes of dehydration ISF is trans-
ferred to the plasma, offsetting the loss of fluid from the
plasma volume.
The infusion of fluids to more rapidly restore fluids in
patients with diarrhea and dehydration did not wait for
an understanding of body fluid physiology and body fluid
compartments. The first reported case of the use of fluid
therapy appeared in the Lancet in 1832 [13]. Latta re-
ported using a solution of salt, sodium bicarbonate, and
water to replace diarrheal losses in a cholera patient. This
technique was not incorporated into practice until 60 to
70 years later, however, when sterile distilled water and
improved equipment made the infusion of fluids safer. In
1918, Blackfan and Maxcy reported using intraperitoneal
injections of saline to treat dehydration from diarrheal ill-
nesses [14]. In 1931, Karelitz and Schick used continuous
intravenous drips to treat dehydration [15]. The success
of these techniques in children was quite impressive given
the difficulty at that time with infusion techniques. Con-
cepts regarding body fluid compartments and body fluid
physiology were still in their formative years.
Our modern-day view of intravenous fluid therapy and
oral rehydration therapy (ORT) is based on our un-
derstanding of fluid compartments. The definition and
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quantitative understanding of ECF as described by Gam-
ble was an important milestone. In 1960, Darrow, a major
contributor to our understanding of body fluid physiology
and its correction during dehydration, described Gam-
ble’s work on ECF as his greatest contribution and one
that forms the basis for modern fluid therapy [16].
Darrow contributed significantly to our understanding
of body fluid physiology and what it took to repair alter-
ations in body fluids. His concept of “deficit therapy” as
part of fluid therapy has been an important fixture in most
prescriptions of fluid therapy. Deficit therapy is a method
of replacing previous losses from the extracellular and
intracellular fluid spaces. It is a slow form of fluid re-
placement therapy calculated over several hours or even
days, depending on the severity of the dehydration and
severity of the electrolyte derangements. Experiments
performed in the 1930s demonstrated a redistribution
of total body water following a change in ECF volume
as well as changes in ECF electrolyte composition. Us-
ing a clever experimental technique, Darrow and Yannet
demonstrated that a change in ECF electrolyte levels,
specifically hyponatremia and the resultant hypotonic-
ity, produced a loss in both ECF and intracellular fluid
(ICF). Therefore, correction of the full electrolyte loss of
salt and water depletion requires replenishment of the
ICF component of total body water as well as the ECF.
Restoration of ECF alone, although helpful, would not
suffice. These findings introduced the concept of deficit
therapy [17, 18].
Darrow et al added two other important concepts to
fluid therapy. The first was tying the “maintenance” al-
lowance of water in a 24-hour period to metabolic rate
rather than body weight. Maintenance therapy is the
provision of fluid and electrolytes to replace anticipated
losses from breathing, sweating, and urine output. It is
usually calculated to replace the upcoming 24 hours of
water and electrolyte losses. This concept became the
basis for maintenance fluid requirements termed the
“Holliday-Segar method,” a guide for 24-hour total wa-
ter requirements for children [19]. Darrow’s second im-
portant contribution was recognizing the importance of
potassium deficiency in dehydration, especially diarrheal
dehydration, and noting that potassium deficiency was a
significant component of metabolic alkalosis often asso-
ciated with extracellular volume contraction [20].
The importance of potassium deficiency logically led
to another critical change in fluid therapy: the addition of
potassium to parenteral fluid therapy regimens. Darrow
et al recognized that potassium loss was indeed part of
the dehydration of diarrhea, then a common cause of
dehydration and death [21, 22]. The addition of potas-
sium in parenteral fluid significantly improved survival
rates in children with diarrheal dehydration. Darrow
et al understood that parenteral fluid therapy with potas-
sium needed to be given slowly to avoid the risk of hy-
Table 1. Twenty-four–hour maintenance water requirement
in children
Holliday-Segar
≤10 kg 100 mL/kg/24 hr
11–20 kg 1000 mL + 50 mL/kg/24 hr for
each kg from 11–20
>20 kg 1500 mL + 20 mL/kg/24 hr for
each kg >20
Simplified method (based
on Holliday-Segar)
<10 kg 4 mL/kg/hr
11–20 kg 40 + 2 mL/kg/hr for
each kg between 11–20
60 + 1 mL/kg/hr for each kg >20
Body surface area method
1500 mL/m2/24 hr
BSA
√
wt(kg) × (ht)cm
3600
Adult estimate
2–3 L/24 hrs
perkalemia [23]. Thus, deficit therapy became a slower
form of fluid replacement therapy designed to expand
extracellular fluid and to replace sodium and potassium
losses.
Maintenance therapy and deficit therapy
The net result of more than half a century of clinical
studies is a formulaic view of fluid and electrolyte therapy.
Physicians now understand the concepts of maintenance
therapy and deficit (rehydration) therapy. Maintenance
therapy (for upcoming losses) and deficit therapy (for
previous losses) are calculated as part of overall fluid
therapy. We define maintenance therapy as the fluid and
electrolyte requirements needed by the average individ-
ual with normal ICF/ECF volumes over a 24-hour period.
Intravenous fluids are generally used when a patient is un-
able to take oral fluids for 24 to 48 hours or more. In chil-
dren, especially in premature babies, infants, and young
children, the inability to ingest fluids for even 8 to 12 hours
can be sufficient to require intravenous maintenance flu-
ids. An examination of a number of commonly used
resources points to three methods for determining main-
tenance water requirements in children: the Holliday-
Segar formula, a simplified Holliday-Segar formula, and
a formula based on body surface area for children more
than 10 kg [24–27] (Table 1).
Maintenance electrolyte requirements in children are
generally considered 3 mEq of sodium, 2 mEq of chlo-
ride, and 2 mEq of potassium for every 100 mL of mainte-
nance IV fluid. Meeting these requirements is most easily
accomplished by using a solution that contains a small
amount of carbohydrate, 5% dextrose, plus 0.25 normal
saline plus 20 mEq/L of potassium chloride. Interestingly,
in adult patients, the most commonly suggested mainte-
nance solution is 5% dextrose, plus 0.45 normal saline
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plus 20 to 30 mEq/L of potassium chloride [26, 27]. The
precise reason for the higher sodium content in adults is
unclear, although some references allude to the greater
risk of hyponatremia in the elderly. One common mistake
in the pediatric age group is providing electrolytes on a
per kilogram basis as opposed to per 100 mL of mainte-
nance IV fluid.
I offer this seemingly elementary, but often neglected,
material here for two reasons. First, maintenance fluid
should be viewed as no more than the usual water and
electrolyte requirements for the next 24 hours in an oth-
erwise normal individual. It takes into account average
water and electrolyte losses in urine and feces (sensible
losses) and insensible losses (water lost in evaporation
across the skin and in expired air) as well. But one must
keep in mind exceptions to maintenance requirements.
Fluid requirements increase in patients with high solute
loads, such as glucosuria and diabetic ketoacidosis, or se-
vere catabolism with high protein losses, such as burns
or crush injuries. Other examples include uncontrolled
diabetes insipidus with very high urinary losses of water
and increased insensible losses from fever or an increased
respiratory rate. Decreased free water requirements re-
sult from excessive antidiuretic hormone (ADH) secre-
tion, which leads to a concentrated urine (for example,
SIADH). Excess ADH secretion can result from postop-
erative stress, persistent nausea, coma, head injury, and
positive pressure ventilation, to name just a few under-
lying stimuli. Oliguria, as a result of renal insufficiency,
also can reduce maintenance requirements, and situa-
tions of decreased insensible loss, such as ventilator use
with fully humidified air, will lower maintenance fluid re-
quirements. Second, in hospitalized patients, as a means
of increasing urine output, the total fluid intake often
is calculated as a multiple of maintenance fluid require-
ments. For example, certain oncology protocols specify
that a patient receive 1 1/2 or 2 times maintenance fluid
as a way of assuring high fluid intake and high urine vol-
umes. While simple, this use of the term “maintenance”
is inappropriate. Complicated patients on protocols
often have other medical problems that call for a dif-
ferent electrolyte solution; indeed, if one wants to main-
tain a diuresis, abundant evidence indicates that water
alone and/or solutions such as normal saline are better
choices.
I must comment on a recent report analyzing main-
tenance fluid therapy. Moritz and Ayus cite articles in
which hyponatremia in hospitalized patients has caused
brain damage or even death [28]. Most of the patients
were admitted for acute medical or surgical illnesses, diar-
rheal dehydration, or even elective surgery [29, 30]. These
authors conclude that hypotonic maintenance therapy
is responsible for these episodes of hyponatremia, and
state that therefore fluid therapy for hospitalized children
should comprise isotonic saline.
This approach is problematic. Most reports of hypona-
tremia as a result of fluid therapy have involved spe-
cific situations in which maintenance therapy was applied
erroneously [31]. In some cases, maintenance therapy
was estimated or was indexed to body weight and not
metabolic rate; thus, too much electrolyte-free water was
provided to the patient. In others, maintenance therapy
was used as a deficit therapy for which it was not designed.
In some instances, the average maintenance therapy pre-
scribed for the patient was inappropriate because the
patient had reduced urine output due to stress-induced
diuresis, which limited electrolyte-free water excretion.
In these situations, the more appropriate response is to
calculate maintenance therapy (Table 1) and to provide
such a therapy only for maintenance and not for repair
of deficits. Finally, in instances in which a reduction in
electrolyte-free water excretion can be anticipated, such
as stress (surgery and postoperative care), nausea and
vomiting, the use of certain medications, or head injury,
average maintenance therapy should be reduced to one
half to two thirds of that calculated for the patient.
For one specific type of patient, the use of isotonic
saline as an intravenous solution does have some valid-
ity. Patients undergoing elective surgery can have an in-
travenous catheter placed prior to surgery that can be
infused with isotonic saline at a “keep open” rate so
that fluid can be administered to replace fluids lost dur-
ing surgery. During surgery, isotonic saline or lactated
Ringer’s solution can be used to maintain perfusion or
to replace blood or fluid losses; an intravenous catheter
also ensures access for drug administration. After surgery,
if fluid therapy is needed, isotonic saline or lactated
Ringer’s solution should be provided at one-half the av-
erage maintenance because of anticipated stress-induced
antidiuresis. Clearly, episodes of hyponatremia induced
by inappropriate fluid therapy have and will make their
way into the literature. However, administration of high
volumes of isotonic solution that results in peripheral
edema, heart failure, or hypertension are not likely to
appear in the literature but could very easily result from
the recommendation of using isotonic fluids or mainte-
nance therapy.
Rapid rehydration therapy: A new approach
In dehydrated (volume-depleted) patients, certain ba-
sic tenets apply regarding management. First, one must
estimate the degree of dehydration to be able to deter-
mine the prescription for rehydration, including amount
of fluid, type of electrolyte solution, and mode of admin-
istration. In children, clinical signs have been adopted as a
standard method for determining degree of dehydration
(percentage of body weight lost) (Table 2).
The majority of dehydrated patients whom physicians
see have suffered acute fluid loss from an illness that
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Table 2. Clinical signs of dehydration
Mild Moderate Severe
1% to 5% 6% to 9% 10% to 15%
Weight 1–5% 6–9% 10%–15%
decrease decrease decrease
Skin: turgor Normal Tenting None
Skin: touch Normal Dry Clammy
Buccal mucosa: lips Moist Dry Parched
Buccal mucosa: eyes Normal Intermediate Sunken
Pulse Regular Increased Very rapid
Urine output Normal Reduced Oliguria
Babies
Fontanelle Flat Soft Sunken
Aspect Consolable Irritable Lethargic
generally has lasted less than one week. This is impor-
tant because most of the fluid lost by that patient comes
from the ECF. Estimates made by Gamble [32] suggest
that fluid losses occurring in fewer than 3 days are be-
tween 75% to 100% from the ECF; between 3 to 7 days,
the figure is probably closer to 60% to 75% from ECF.
Fluid losses for longer than 7 days are a combination of
ECF (50%) and ICF (50%).
The importance of rapid ECF replacement was nicely
demonstrated by Holliday et al in their examination of
the literature about three forms of shock—burns, hem-
orrhagic shock, and septic shock [33]. In shock, the ECF,
especially ISF, moves into the injured area in the case
of a burn, into the circulation in the case of hemor-
rhagic shock, or as a maldistribution of extracellular and
plasma fluid in the case of septic shock. In each in-
stance, patients improve and mortality rates decline in
the presence of a rapid, generous expansion of the ECF
so that both plasma and ISF volumes are expanded. Of-
ten, the total fluid amount given in the first 6 to 12 hours
approximates 100 mL/kg of an ECF-type fluid, such as
normal saline or lactated Ringer’s solution. The major
take-home lesson is the benefit of rapid restoration in
ECF volume.
Can the lessons learned from rapid ECF replacement
in shock be useful in more common dehydration con-
ditions? I believe that the answer is yes. As early as
the 1970s, Hirschhorn et al demonstrated success using
a more rapid ECF restoration regimen than that used
following Darrow’s deficit approach [34]. The report doc-
uments the use of ORT for children with diarrheal dehy-
dration. The arguments for more rapid ECF rehydration
regimen were (1) improved gastrointestinal perfusion, al-
lowing earlier oral feeding; (2) improved renal perfusion,
allowing more rapid correction of sodium, potassium, and
acid-base abnormalities, often without special measures
for achieving these corrections; and (3) an excellent re-
covery rate with a low morbidity and mortality rate [30].
The volumes provided to accomplish this type of rehy-
dration were equivalent to 100 to 120 mL/kg of normal
saline in the first 24 hours. This time period needed with
oral replacement is longer than that with intravenous re-
placement.
The American Academy of Pediatrics (AAP), in a sub-
committee report on acute gastroenteritis, reviewed the
management of diarrhea and offered recommendations
for its therapy in 1996 [36]. The committee defined de-
hydration as shown in Table 2, recommended that only
infants with moderate (6% to 9%) or severe (greater
than 10%) dehydration should have serum chemistries
determined, and recommended the initial use of intra-
venous rehydration in patients with severe dehydration.
In the description of intravenous rehydration, they noted
that, “a common recommendation is to give 20 mL/kg
(of normal saline or lactated Ringer’s solution) during
a 1-hour period. However, larger quantities and much
shorter periods of administration may be required (to
achieve rehydration).” They further defined rehydration
as (1) restoration of skin turgor and weight; (2) recovery
of alertness; (3) tolerance to oral intake of formula; and
(4) correction of serum chemistries.
As I discussed, the important message from the treat-
ment of shock is that rapid ECF volume replenishment
improves patient outcomes [37–40]. This along with work
by Hirschhorn [34] and the AAP management recom-
mendation for dehydration [36] provides convincing ev-
idence for rapid extracellular volume restoration that
cannot be obtained by the usual deficit therapy. I sug-
gest a revised approach to the therapy of rehydration—
here termed “rapid rehydration therapy.” This approach
is consistent with recommendations already promulgated
[36] and takes into account the advantages of rapid ECF
volume restoration noted earlier. (1) In patients with
mild dehydration, oral rehydration therapy (up to 50
mL/kg over 12 to 24 hours) alone should be sufficient.
(2) In patients with moderate dehydration, oral rehydra-
tion therapy (25 to 50 mL/kg over 6 to 12 hours) should
be sufficient. However, if intravenous rehydration is uti-
lized, ECF should be rapidly restored by administering
lactated Ringer’s solution at 40 mL/kg in 1 to 2 hours,
with the initiation of ORT after completion of the intra-
venous infusion. (3) In patients with severe dehydration,
weight loss of 10% or greater, impaired circulation (as
measured by rapid pulse and a reduced capillary fill time),
and evidence of ISF fluid loss (including loss of skin tur-
gor and sunken eyes), ECF should be rapidly restored via
administration of intravenous lactated Ringer’s solution
and/or normal saline at 40 mL/kg over 1 to 2 hours; if
skin turgor, alertness, or pulse do not return to normal by
the end of the infusion, one should infuse an additional
bolus of 20 to 40 mL/kg over 1 to 2 hours. ORT then
can be initiated as soon as oral intake is tolerated. Oral
rehydration solutions with lower sodium concentrations
(45–60 mEq/L) are appropriate for patients with mild to
moderate dehydration, but higher sodium concentrations
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Table 3. Fluid replacement therapy
Moderate dehydration ∼7% (70 mL/kg)
Wt (15 kg) Water mL Na+mEq K+mEq
Maintenance (Holliday-Segar) 1250 37 25
Deficit (1000) (Darrow)
ECF 75% 700 114
ICF 25% 250 37
Additional Na+a 63
Total 2250 214 62
D5 0.45 NS + 30 mEq KCl/L at 100 mL/hr for 24 hours.
aAdditional Na+ (135–128) × 15 (body weight in kg) × 0.6 (total body water =
60% of body weight) = 63.
(75–90 mEq/L) are best suited for patients with severe
dehydration and/or persistent diarrhea [33].
Let’s return to today’s patient. This little boy has mod-
erate dehydration as defined in Table 2. Routine fluid re-
placement therapy for the first 24 hours would accomplish
the desired effect of providing the patient with both main-
tenance and deficit (rehydration) fluid, although comple-
tion of rehydration would take most of the first 24-hour
period (Table 3).
Maintenance following the Holliday-Segar method for
a 15 kg child equals 1250 mL of water (1000 mL for the
first 10 kg plus 50 mL/kg for the next 5 = 1250 mL).
Maintenance sodium is 3 mEq/100 mL fluid = 37 mEq of
sodium; maintenance potassium is 2 mEq/100 mL fluid =
25 mEq of potassium. In addition, standard deficit ther-
apy would require 1 L of fluid (7% of 15 kg) with 75%
calculated as ECF replacement (given the length of time
of illness). Therefore, 750 mL of NS that would pro-
vide 114 mEq of sodium (0.75 × 154 mEq of sodium) is
recommended. Twenty-five percent is calculated as ICF
replacement; ICF contains approximately 150 mEq of
potassium per liter, so 250 mL would require approxi-
mately 37 mEq of potassium. Finally, the patient’s serum
sodium is 128 mEq/L. To bring a 15 kg child with a serum
sodium of 128 to a serum sodium in the normal range—
135 mEq/L—would require an additional 63 mEq (see
Table 3 for calculation). In total, fluids required for main-
tenance plus deficit therapy can be obtained by a solution
that approximates 0.45 normal saline (NS) with 30 mEq/L
of potassium. In 24 hours, 2250 mL of solution would be
needed; therefore, an infusion rate near 100 mL/hr would
provide maintenance plus deficit for this patient.
If intravenous therapy were used, the first step would
be to provide the patient with 40 mL/kg of NS or lactated
Ringer’s (LR) solution as rapidly as possible (for exam-
ple, over 1 to 2 h). Based on a weight of 15 kg (15 × 40
mL), this patient would require 600 mL of water, approx-
imately 78 mEq LR, and 92 mEq of sodium using NS.
We’d then give him ORT, and his feedings would begin
as quickly as tolerated; 600 mL of an “ECF-like solution”
would rapidly restore nearly all the extracellular fluid
losses. The rest of the rehydration of ECF as well as ICF,
Table 4. “Revised rehydration therapy”
Stepwise approach
Moderate dehydration ∼7% (70 mL/kg), 15 kg patient
1. IV + oral route
a. IV: 40 mL/kg normal saline (NS) or lactated Ringer’s
(LR) over 1–2 hours = 600 mL
b. ORT
2. Oral rehydration therapy (ORT)—WHO formula (≥60 mEq
NaCl/L) IV + oral route
3. IV only
a. 40 mL/kg NS or LR over 1–2 hours
b. Additional bolus 10–20 mL/kg NS or LR to normalize
cardiovascular signs, if needed
c. Start maintenance fluids as in Table 3 over 24 hours.
Replace additional sodium and potassium if needed as in
Table 3.
along with the provision of potassium, would be accom-
plished more slowly by the oral rehydration fluid. Finally,
if for some reason deficit (rehydration) and maintenance
therapy needed to be provided intravenously only, we first
would give 40 mL/kg of NS or LR over 1 to 2 hours. Thus,
nearly all the calculated ECF loss would be replaced. If
the patient still appeared to need further IV replacement
(for example, if he were tachycardic), we then would ad-
minister an additional 10 to 20 mL/kg bolus of NS or LR
over 1 to 2 hours to complete extracellular fluid volume
replacement. Over the next 16 to 24 hours, maintenance
fluids (Holliday-Segar method), perhaps with additional
sodium and potassium replacement, would be used.
Let me summarize. Extracellular fluid volume restora-
tion plays a major, if not predominant, role in the therapy
of most patients with dehydration. What I have termed
“rapid rehydration therapy” aims at a rapid restoration
of ECF (followed by maintenance therapy) and is both
safe and effective for the overwhelming majority of pa-
tients. It is now time for us to refine our understanding
of the treatment of dehydration and to recognize that
“rapid rehydration therapy,” as opposed to “deficit ther-
apy,” is the more appropriate treatment for children with
dehydration.
QUESTIONS AND ANSWERS
DR. TODD VARNESS (Department of Pediatrics, Univer-
sity of Wisconsin Children’s Hospital, Madison, Wiscon-
sin): When we prescribe intravenous fluid, on occasion
we also suggest using additional fluids to replace a por-
tion of ongoing daily losses. But that seems akin to the
deficit approach: we’re putting back what we think the
patient will lose. How should we best handle the issue of
ongoing daily losses?
DR. FRIEDMAN: The point you’re raising is a third
component to fluid therapy. What we’ve talked about is
maintenance therapy and replacement of deficits, that is,
replacing what was lost. However, when you anticipate
ongoing losses such as continued diarrheal losses, what
386 Nephrology Forum: Hydration therapy in children
do you do about the ongoing losses? When a predictable
amount is going be lost during a 24-hour period, you
should build that into the patient’s fluid therapy. It’s not
replacing a previous loss, and it’s not providing mainte-
nance fluids; rather it’s simply keeping up with an ongoing
loss, which makes sense.
DR. BRANDON NATHAN (Department of Pediatrics,
University of Wisconsin Children’s Hospital): My ques-
tion relates to hyponatremic dehydration. Is there a level
at which we need to be conservative about rehydration
therapy? How low can the serum sodium concentration
fall before one has to be more concerned about provid-
ing a more aggressive rehydration approach with isotonic
fluids, as you suggested? Considering the potential risks
of central pontine myelinolysis (CPM), can one continue
using normal saline or Ringer’s lactate?
DR. FRIEDMAN: I’m glad you asked that. The literature
reveals that clinicians fear that changing the sodium con-
centration too rapidly in either direction is a risk. If the pa-
tient has hypernatremic dehydration, lowering the serum
sodium level too rapidly can induce cerebral edema; and
in hyponatremia, if you raise the serum sodium level too
rapidly or increase the osmolality too fast, you run the
risk of causing CPM. It’s an interesting discussion; CPM
is a very uncommon result in children, and it appears to
be an issue that involves the adult brain more than the
child’s brain [33]. Presumably the risk is there in children;
however, children at risk usually are patients with long-
standing illness in whom hypotonicity, not volume deple-
tion, is the issue. CPM does not result from the restoration
of extracellular volume from low to normal.
DR. JOHN T. HARRINGTON (Dean Emeritus, Tufts-New
England Medical Center, Boston, Massachusetts): Let me
add a comment regarding volume status in patients with
CPM. A lot of work done over the past 15 to 20 years
showed that adult patients who have rapid correction of
severe hyponatremia develop CPM. Most of these pa-
tients have been hypotonically volume expanded, not
depleted. In most patients who are hypotonic and vol-
ume depleted, restoration of ECF volume corrects the
hyponatremia by inhibiting secretion of antidiuretic hor-
mone. Electrolyte-free water is excreted in the urine, and
serum sodium concentration returns to normal. These
volume-depleted patients are not the problem; the prob-
lem is non–volume-depleted patients who are hypona-
tremic. When hyponatremia is rapidly corrected in that
setting, given the changes in cerebral osmolality 2 to
3 days later, one can produce CPM.
DR. ROBERT BENJAMIN (Department of Pediatrics,
University of Wisconsin Children’s Hospital): In the emer-
gency room, the topic of oral rehydration therapy comes
up time and again. We recommend Pedialyte, even
though this solution might not be as effective as the World
Health Organization (WHO) formula, which contains 60
to 90 mEq/L of sodium. Can you suggest other solutions
or tell us where we might find other information that we
can share with our patients? The other problem besides
choosing an appropriate rehydration solution is ensur-
ing that the patient does not vomit. Even when patients
are <10% dehydrated, we have the problem of treat-
ing a dehydrated-looking 13-month-old who has no visi-
ble vasculature, but we are forced to administer fluid in-
travenously nonetheless, because the child continues to
vomit.
DR. FRIEDMAN: That’s the most common feature of
many patients who have gastroenteritis with diarrhea and
continued vomiting. This problem has been examined
around the world because cholera is not the only thing
that results in diarrheal dehydration. Frequent feeding of
small volumes does result in children being rehydrated.
The attempt to get many ounces of fluid into a patient in
one sitting doesn’t work. Small, frequent amounts work
best, and it’s labor intensive. You can set an IV at a cer-
tain rate and walk away and the patient will receive fluids.
Oral rehydration does keep people out of the hospital, it
does rehydrate them, and it’s quite effective. I think the
reason Pedialyte works most of the time is that for mild
to moderate dehydration, even a solution containing 40
to 45 mEq/L of a sodium solution will be sufficient. It’s
only when the patient is more severely dehydrated and
has a rapid pulse and changing blood pressure that oral
rehydration might not be fast enough. That is the time
when I think utilization of rapid rehydration provided
intravenously (rapid rehydration) approach, followed by
oral rehydration is sensible. Hirschhorn makes an impor-
tant point: reperfusion of the gut and reperfusion of the
kidney make a difference to how much one can consume
orally [34]. Dr. Tuffli, you might want to comment.
DR. GORDON TUFFLI: To optimize electrolyte absorp-
tion from the gut, you need equimolar amounts of glu-
cose. Pedialyte doesn’t provide equimolar amounts of
glucose and sodium. The WHO rehydration packets are
equimolar, but they are not readily available at drug
stores or pharmacies. Our patients’ parents come to us for
help; they want us to prevent them from having to stay up
all night. Asking them to administer a teaspoon or two of
fluid every 5 minutes is just not going to be greeted with
much enthusiasm, and my guess is that compliance will be
less than maximal. It is difficult in our society to achieve
good rehydration by the oral route, but it can be done
more effectively with solutions other than Pedialyte.
DR. HARRINGTON: Could you lay out the underlying
rationale for using glucose in oral rehydration therapy?
What is the true relationship between glucose and gas-
trointestinal sodium transport?
DR. FRIEDMAN: It’s a really interesting story. In the
1920s and 1930s, physicians believed that if we could just
give fluids orally instead of intravenously, we could re-
hydrate patients. So the original solutions were approx-
imately D5-half-normal saline. Unfortunately, there was
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an increase in mortality rates when that solution was used,
and that problem set back oral rehydration therapy for a
generation. Dr. Tuffli alluded to the finding that the prob-
lem was too much glucose. Therefore, a solution that was
more like D2, just 2% glucose, would be very effective
because the transporter for glucose in the gut is a sodium-
dependent transporter. If you could maximize the glucose
that was absorbed, glucose would not be provided to the
colon as a substrate for natural growth and also would
not serve as an osmotic agent and produce more diar-
rhea. Sodium transport and glucose transport together
were improved when the concentration of glucose and the
concentration of sodium were equimolar. That’s the key
point. After that was determined, oral rehydration solu-
tions became much more commonly used and, of course,
much more effective.
DR. HARRINGTON: I was struck by your comment on
fluid/electrolyte replacement, that is, that we don’t look
at the other half of it—salt and water overload—for ex-
ample, pulmonary edema. Some time ago, I was inter-
ested in hospital-acquired hyperkalemia [41]. It was clear
from the literature that the most potent single drug that
caused death in hospitals was potassium, particularly in-
travenous potassium; yet we all use it like candy. Has
anyone systematically analyzed the issue of sodium over-
load in patients treated with “deficit therapy” rather than
your newly proposed “rapid rehydration therapy”?
DR. FRIEDMAN: I haven’t, and I don’t know of any
studies on this issue.
DR. CHRISTOPHER BIRN (PGY-3 Pediatric Resident,
University of Wisconsin Children’s Hospital): I’d like to
return to oral rehydration. One problem I often en-
counter is a dehydrated child who won’t take Pedi-
alyte. These patients sometimes will drink half-strength
Gatorade or half-strength juice. What should I recom-
mend to the parents? Is half-strength Gatorade or is juice
sufficient, or is water all right? Or should I push harder
for the Pedialyte? Should I just tell them to come in for
the IV because what they’re doing is not going to be
effective?
DR. FRIEDMAN: Obviously, lots of children have di-
arrhea and vomiting and they get by without receiving
intravenous fluids. With a self-limited illness, one im-
provises with time as long as the dehydration is not too
severe. Parents have used tricks, like freezing Pedialyte
and using that as a Pedialyte Popsicle; some people say
that that approach works. If you’re trying to give small
amounts of fluid in frequent intervals as opposed to try-
ing to give six ounces at once, there seems to be more suc-
cess. I don’t know what to tell you. Have you ever tasted
Pedialyte? You all should taste it at least once. It’s very
salty.
The last point is that dehydrated patients do feel better
after receiving IV saline. Patients feel better and probably
will be able to ingest additional fluids orally if they are
rehydrated. But IV rehydration is not that simple either.
Say your patient is a 13-month-old, pudgy child. You’re
looking for a vein so you can administer 40 mL/kg of
normal saline. It takes a lot of time and effort to place an
IV in a busy clinic or emergency room. It’s not simple any
way you look at it, but basically, the more fluid you can
get into the patient, the faster you’ll be able to get more
in orally because of improved gut function.
DR. HARRINGTON: The Boston Globe recently ran a
remarkable story about a marathon runner who died af-
ter the race with severe hyponatremia. That doesn’t make
sense to those of us from the pre-Gatorade generation,
because if you run a marathon, you sweat, and you lose
hypotonic fluids. The serum sodium concentration should
rise, not fall. This unfortunate woman obviously had re-
lease of antidiuretic hormone from running, stress, and
volume depletion; she drank too much hypotonic fluid,
became hyponatremic, and died shortly after the race.
That is an extreme example of why we’re so concerned
about hyponatremia.
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